Subscribe

Colorectal Carcinoma | Score for Predicting Severe Diarrhea Following Chemo

Purpose:

To identify a patient with colorectal cancer who is at risk for severe diarrhea following FOLFOX or FOLFIRI chemotherapy.

Specialty:

Hematology Oncology
Gastroenterology
Clinical Pharmacology & Toxicology

Objective:

severity, prognosis, stage, adverse effects

ICD-10:

T45.1

Description:

Dranitsaris developed a score for identifying patients at risk for severe diarrhea following chemotherapy for advanced colorectal cancer. The authors are from the British Columbia Cancer Agency, the Humber River Regional Cancer Centre (Toronto) and the London Regional Cancer Program (Ontario) in Canada.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone